Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Disclosure Regarding Additional Risks in Direct-to-Consumer Prescription Drug Television Advertisements

Özet

The Food and Drug Administration (FDA) is announcing that a collection of information entitled, "Disclosure Regarding Additional Risks in Direct-to-Consumer Prescription Drug Television Advertisements" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.